0001894562-24-000004.txt : 20240119
0001894562-24-000004.hdr.sgml : 20240119
20240119161941
ACCESSION NUMBER: 0001894562-24-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240117
FILED AS OF DATE: 20240119
DATE AS OF CHANGE: 20240119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reine Allan
CENTRAL INDEX KEY: 0001714023
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41536
FILM NUMBER: 24545832
MAIL ADDRESS:
STREET 1: C/O PIERIS PHARMACEUTICALS, INC.
STREET 2: 255 STATE STREET
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prime Medicine, Inc.
CENTRAL INDEX KEY: 0001894562
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-465-0013
MAIL ADDRESS:
STREET 1: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wk-form4_1705699169.xml
FORM 4
X0508
4
2024-01-17
0
0001894562
Prime Medicine, Inc.
PRME
0001714023
Reine Allan
C/O PRIME MEDICINE, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
0
Stock Option (right to buy)
6.80
2024-01-17
4
A
0
600000
0
A
2034-01-17
Common Stock
600000
600000
D
25% of the shares underlying this option shall vest and become exercisable on January 17, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Marishka DeToy, attorney-in-fact
2024-01-19